Trial Profile
High dose intravenous immunoglobulin for the treatment of autoimmune bullous diseases
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Jun 2022
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Vesiculobullous skin diseases
- Focus Therapeutic Use
- 20 May 2016 Except pemphigus vulgaris, patients diagnosed with all other autoimmune bullous disease were enrolled in this study.
- 19 May 2016 New trial record